CVE:IOT Innovotech (IOT) Stock Price, News & Analysis C$0.21 0.00 (0.00%) As of 09/5/2025 02:51 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesInsider TradesBuy This Stock About Innovotech Stock (CVE:IOT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Innovotech alerts:Sign Up Key Stats Today's RangeC$0.21▼C$0.2250-Day RangeC$0.21▼C$0.3452-Week RangeC$0.10▼C$0.34Volume16,000 shsAverage Volume52,746 shsMarket CapitalizationC$10.51 millionP/E Ratio38.29Dividend Yield10.00%Price TargetN/AConsensus RatingN/A Company Overview Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada. Read More Receive IOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Innovotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IOT Stock News HeadlinesInnovotech Reports Strong Q2 Revenues Amid Strategic ExpansionAugust 20, 2025 | msn.comInnovotech With President, Director & CEO Craig MilneMay 23, 2025 | msn.comBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. September 7 at 2:00 AM | Crypto 101 Media (Ad)Public market insider buying at Innovotech (IOT)May 20, 2025 | theglobeandmail.comInnovotech Secures Funding to Advance Antimicrobial Testing and Product DevelopmentMay 8, 2025 | tipranks.comInnovotech Achieves Record Annual Revenue and Positive Net Income for 2024April 18, 2025 | seekingalpha.comAre Innovotech Inc.'s (CVE:IOT) Mixed Financials Driving The Negative Sentiment?April 17, 2025 | finance.yahoo.comInnovotech Reports Record Revenue and Profit for 2024April 16, 2025 | tipranks.comSee More Headlines IOT Stock Analysis - Frequently Asked Questions How have IOT shares performed this year? Innovotech's stock was trading at C$0.18 on January 1st, 2025. Since then, IOT stock has increased by 16.7% and is now trading at C$0.21. How do I buy shares of Innovotech? Shares of IOT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Innovotech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Innovotech investors own include Absolute Software (ABST), Ford Motor (F), Agiliti (AGTI), PlayAGS (AGS), Ares Capital (ARCC), Century Bancorp (CNBKA) and Chevron (CVX). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryComputer Software Current SymbolCVE:IOT CIKN/A Webwww.incomeopp-realty.com Phone+1-780-4480585FaxN/AEmployees1,620Year FoundedN/AProfitability EPS (Trailing Twelve Months)C$0.01 Trailing P/E Ratio38.29 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net Margins-29.67% Pretax MarginN/A Return on Equity-39.52% Return on Assets-33.01% Debt Debt-to-Equity Ratio12.55 Current Ratio2.63 Quick Ratio5.81 Sales & Book Value Annual SalesC$3.62 million Price / Sales2.90 Cash FlowC$0.02 per share Price / Cash Flow10.71 Book ValueC$0.02 per share Price / Book10.50Miscellaneous Outstanding Shares50,031,000Free FloatN/AMarket CapC$10.51 million OptionableNot Optionable Beta2.06 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (CVE:IOT) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.